Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Colorectal Carcinoma
100%
Inflammatory Bowel Disease
100%
Mammalian Target of Rapamycin
100%
Mammalian Target of Rapamycin Inhibitor
42%
Malignant Neoplasm
14%
Colon Carcinoma
14%
Inflammation
14%
Neoplasm
14%
Clinical Trial
14%
Drug Resistance
14%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
14%
Cancer Model
14%
Adaptor Protein
14%
Mammalian Target of Rapamycin Complex 1
14%
Mammalian Target of Rapamycin Complex 2
14%
Bacterial Clearance
14%
Medicine and Dentistry
Colorectal Carcinoma
100%
Infectious Disease
100%
Inflammatory Bowel Disease
100%
Medicine
28%
Malignant Neoplasm
14%
Clinical Trial
14%
Drug Resistance
14%
Cancer Model
14%
Cell Metabolism
14%
Genetic Transcription
14%
Immunocompetent Cell
14%
Colon Carcinoma
14%
Mammalian Target of Rapamycin
14%
Cell Differentiation
14%
Paneth Cell
14%
Adaptor Protein
14%
Adaptive Immunity
14%
Bacterial Clearance
14%
Protein Synthesis
14%
Tumor Metabolism
14%
Innate Immunity
14%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
14%
Goblet Cell
14%
Immunology and Microbiology
Sirolimus
100%
Autophagy
30%
Protein Synthesis
10%
Cell Expansion
10%
Colon
10%
Goblet Cell
10%
Paneth Cell
10%
Bacterial Clearance
10%
Innate Immune System
10%
Mammalian Target of Rapamycin Complex 2
10%
Mammalian Target of Rapamycin Complex 1
10%